Copyright
©The Author(s) 2025.
World J Clin Oncol. Apr 24, 2025; 16(4): 105077
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.105077
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.105077
Table 1 Previously reported cases of oxaliplatin-induced diffuse alveolar hemorrhage
Characteristics | Kumaran et al[6] | Lou et al[5] | Watkins et al[2] | Present case |
Types of cancer | Unknown primary | Esophageal | Colorectal | Esophageal |
Regimen | Oxaliplatin | FOLFOX | FOLFOX | FOLFOX and S-1 |
Chemotherapy before onset | 1 cycle | 1 cycle | 11 cycles | 8 cycles |
Mechanical ventilation | Yes | Yes | Yes | Yes |
Treatment | Corticosteroids | mPSL 1 mg/kg | mPSL 125 mg q6h | mPSL 1000 mg |
Timing of corticosteroids | Not addressed | Not addressed | After 3 days of hospitalization | On the day of hospitalization |
Outcome | Extubation | Extubation | Death | Extubation |
- Citation: Tsurui T, Mura E, Horiike A, Tsunoda T. Oxaliplatin-induced diffuse alveolar hemorrhage: A case report. World J Clin Oncol 2025; 16(4): 105077
- URL: https://www.wjgnet.com/2218-4333/full/v16/i4/105077.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i4.105077